Systemic sclerosis & Raynaud's

Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL

Rheumatology (Oxford)Published Validation study

Authors' conclusion

PASTUL is a feasible outcome tool that adds to assessments such as SSPRO. Skin thickening is correlated with HRQoL, particularly in early disease.

Study context

Population
Participants with SSc at four UK centres (mean age 56.4 years, 80.6% female; 110 lcSSc, 81 dcSSc)
Participants
196 participants4 UK centres
Comparison
PASTUL self-assessment vs upper limb modified Rodnan Skin Score (mRSS)
Outcome
Construct validity: agreement of PASTUL scores with mRSS
Methodological detailsmulticentre, 12-month follow-up, Follow-up 12 months
  • Multicentre
  • 12-month follow-up
  • Follow-up 12 months

Performance

As reported in the abstract

Correlation of PASTUL with upper limb mRSS (ICC) · baseline, 6 and 12 months

Intraclass correlation coefficients (ICC) at baseline

0.67

ICC at 6 months

0.78

ICC at 12 months

0.62

Further findings

OutcomeCorrelationP value
Correlation of PASTUL with upper limb mRSS by subsetdcSSc vs lcSSc · stronger correlation in dcSSc0.69 vs 0.51P < 0.001
Time to complete PASTUL self-assessment
5.0 · mean · SD 3.7 · min

Test-retest reliability of PASTUL

ICC
0.83
  • P < 0.001

Correlation of PASTUL with health-related quality of life (HRQoL) in early disease (<4 years) (subgroup)

R
0.53
Correlations weaker in the whole group
  • P < 0.001

Original publication

Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL. Rheumatology (Oxford). Published 14 October 2024. doi:10.1093/rheumatology/keae561

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.